[go: up one dir, main page]

IS4913A - Samsetningar sem innihalda VX 478, Zídóvúdín og/eða 1592489 til að nota við meðhöndlunina á HIV - Google Patents

Samsetningar sem innihalda VX 478, Zídóvúdín og/eða 1592489 til að nota við meðhöndlunina á HIV

Info

Publication number
IS4913A
IS4913A IS4913A IS4913A IS4913A IS 4913 A IS4913 A IS 4913A IS 4913 A IS4913 A IS 4913A IS 4913 A IS4913 A IS 4913A IS 4913 A IS4913 A IS 4913A
Authority
IS
Iceland
Prior art keywords
zidovudine
hiv
treatment
compositions containing
compositions
Prior art date
Application number
IS4913A
Other languages
English (en)
Inventor
Heider St. Clair Martha
Walter Barry David
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614024.9A external-priority patent/GB9614024D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS4913A publication Critical patent/IS4913A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IS4913A 1996-06-25 1998-11-30 Samsetningar sem innihalda VX 478, Zídóvúdín og/eða 1592489 til að nota við meðhöndlunina á HIV IS4913A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2217896P 1996-06-25 1996-06-25
GBGB9614024.9A GB9614024D0 (en) 1996-07-04 1996-07-04 Antiviral therapeutic combinations
PCT/EP1997/003246 WO1997049410A1 (en) 1996-06-25 1997-06-23 Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv

Publications (1)

Publication Number Publication Date
IS4913A true IS4913A (is) 1998-11-30

Family

ID=26309631

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4913A IS4913A (is) 1996-06-25 1998-11-30 Samsetningar sem innihalda VX 478, Zídóvúdín og/eða 1592489 til að nota við meðhöndlunina á HIV

Country Status (26)

Country Link
US (1) US6486136B1 (is)
EP (1) EP0910386B1 (is)
KR (1) KR20000022225A (is)
CN (1) CN1306430A (is)
AP (1) AP9801418A0 (is)
AT (1) ATE230267T1 (is)
AU (1) AU723877C (is)
BR (1) BR9709951A (is)
CA (1) CA2262765A1 (is)
CO (1) CO4910137A1 (is)
CZ (1) CZ429398A3 (is)
DE (1) DE69718168T2 (is)
EA (1) EA001457B1 (is)
ES (1) ES2189964T3 (is)
HU (1) HUP9903098A3 (is)
ID (1) ID18739A (is)
IL (1) IL127350A0 (is)
IS (1) IS4913A (is)
NO (1) NO986035L (is)
NZ (1) NZ333098A (is)
PE (1) PE87398A1 (is)
PL (1) PL330791A1 (is)
TR (1) TR199802703T2 (is)
WO (1) WO1997049410A1 (is)
YU (1) YU58498A (is)
ZA (1) ZA975565B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115461A (en) 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
BR9809124A (pt) * 1997-05-17 2000-08-01 Glaxo Group Ltd Combinação, formulação, farmacêutica, processo para o tratamento de uma infecção por hiv em um animal, infectado, uso de (-)-(1s, 4r)-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il)-2-cicl openteno-1-metanol, e, pacote de paciente
GB9802472D0 (en) * 1998-02-06 1998-04-01 Glaxo Group Ltd Pharmaceutical compositions
MXPA00012842A (es) * 1998-06-24 2004-06-22 Univ Emory Uso de 3'-azido-2',3'-didesoxiuridina en combinacion de drogas adicionales contra el vih para la manufactura de un medicamento para el tratamiento del vih.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
GB9307013D0 (en) * 1993-04-02 1993-05-26 Wellcome Found Therapeutic combinations
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5646180A (en) * 1995-12-05 1997-07-08 Vertex Pharmaceuticals Incorporated Treatment of the CNS effects of HIV

Also Published As

Publication number Publication date
ID18739A (id) 1998-05-07
NZ333098A (en) 2000-08-25
EA001457B1 (ru) 2001-04-23
AU723877B2 (en) 2000-09-07
CA2262765A1 (en) 1997-12-31
HU9903098D0 (en) 1999-10-28
US6486136B1 (en) 2002-11-26
CO4910137A1 (es) 2000-04-24
DE69718168D1 (de) 2003-02-06
HUP9903098A3 (en) 2000-01-28
TR199802703T2 (xx) 1999-03-22
HUP9903098A2 (hu) 1999-12-28
AP9801418A0 (en) 1998-12-31
NO986035L (no) 1999-02-23
PL330791A1 (en) 1999-06-07
AU723877C (en) 2001-08-23
IL127350A0 (en) 1999-10-28
EA199801046A1 (ru) 1999-08-26
ES2189964T3 (es) 2003-07-16
PE87398A1 (es) 1999-01-15
AU3262697A (en) 1998-01-14
YU58498A (en) 1999-11-22
CN1306430A (zh) 2001-08-01
DE69718168T2 (de) 2003-10-23
CZ429398A3 (cs) 1999-05-12
WO1997049410A1 (en) 1997-12-31
KR20000022225A (ko) 2000-04-25
ZA975565B (en) 1998-12-23
EP0910386A1 (en) 1999-04-28
EP0910386B1 (en) 2003-01-02
ATE230267T1 (de) 2003-01-15
BR9709951A (pt) 1999-08-10
NO986035D0 (no) 1998-12-22

Similar Documents

Publication Publication Date Title
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
HUP0200442A3 (en) Azeotrope-like composition comprising 1,1,1,3,3-pentafluorobutane and its use
HUP0104496A3 (en) Compositions comprising 1,1,1,3,3-pentafluorobutane and use of said compositions
ID28846A (id) 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
HUP9903673A3 (en) Treatment of the cns effects of hiv with vx-478,alone or in combination with azt or 3tc
ZA977513B (en) Skin tanning compositions and method.
IS4915A (is) Samsetningar sem innihalda VX478, Zídóvúdín, FTC og/eða 3TC til að nota við meðhöndlunina á HIV
ZA976220B (en) Sulphur reducing bacterium and its use in biological desulphurisation processes.
HUP0004562A3 (en) Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
DK0898566T3 (da) Substituerede benzylaminer og anvendelse deraf til behandling af depression
GB9608485D0 (en) Compositions, processes and uses
GB9608488D0 (en) Compositions, processes and uses
ZA979011B (en) Hormonal composition and its use.
NO992604D0 (no) Oppbygningsundertrykkende midler, blandinger inneholdende slike midler og anvendelse derav i polymeriseringsprosessen
NO984444D0 (no) Benzothiofener, formuleringer som inneholder de samme, og fremgangsmÕter
IS4913A (is) Samsetningar sem innihalda VX 478, Zídóvúdín og/eða 1592489 til að nota við meðhöndlunina á HIV
ID23156A (id) Turunan-turunan amidina, proses pembuatan komposisi dan penggunaannya
FI943069L (fi) Kloorittomia, mahdollisesti vetypitoisia fluorihiilivetyjä sisältävät koostumukset
GB9706136D0 (en) Compositions,processes and uses
GB9706293D0 (en) Compositions, processes and uses
GB9608493D0 (en) Compositions, processes and uses
GB9608487D0 (en) Compositions, processes and uses
EP1032266A4 (en) USE OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION IN THE TREATMENT OF ARTHRITIS
GB9706291D0 (en) Compositions, processes and uses
SI1039894T1 (en) Compositions for increasing the concentration and/or motility of spermatozoa in humans